Overview NexHA™ (hyaluronate sodium) Injectable Solution is indicated in the treatment of joint dysfunction of the carpus or fetlock in horses due to noninfectious synovitis associated with equine osteoarthritis.

  • Treatment may be repeated at weekly intervals for a total of three intravenous treatments
  • Can be used with other joint therapies.
  • No known contraindications
  • FDA-approved generic bioequivalent to Legend®
  • Produced by bacteria, therefore has low protein content with no potential for contamination with materials of animal origin